Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

AstraZeneca7,300 enrolled

Overview

The purpose of this study is to assess in general population low-dose aspirin and gastroprotective agent compliance and reasons for bad compliance

Study Type

OBSERVATIONAL

Enrollment

7,300

Conditions

Self-administered Questionnaire to Patients

Eligibility

Sex: ALLMin age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * French people \> 60 years old, part of Kantar Health Access Sant� panel Exclusion Criteria: -

Outcomes

Primary Outcomes

low-dose aspirin and gastroprotective treatment compliance (Girerd questionnaire: a 6-item self-administered and validated questionnaire to evaluate adherence to treatments)

Time frame: One month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.